Abbott Gets Some DexCom Patent Claims Wiped Out
In a series of six decisions over the past week, the Patent Trial and Appeal Board found that roughly two-thirds of challenged claims in four DexCom patents for glucose monitoring systems...To view the full article, register now.
Already a subscriber? Click here to view full article